Mobile Site ›

80172:
Human Papillomavirus (HPV) Typing, DNA In Situ Hybridization

Test Classification Current Value

This test uses a standard method. Its performance characteristics were determined by Mayo Clinic in a manner consistent with CLIA requirements.

Test Classification Value Prior to 8/04/2014 7:04am

This test was developed using an analyte specific reagent. Its performance characteristics were determined by Mayo Clinic in a manner consistent with CLIA requirements. This test has not been cleared or approved by the U.S. Food and Drug Administration.